Summary
Pahse-III randomized trials are urged to hoopefully confirmed these data. Should that be the case, even brighter future in sight for avastin.
Analysis
Brain tumors are among the deadliest malignancies.
These preliminary results are really impressive.
If avastin confirms this survival benefit in randomized phase III clinical trials, this is going to be a major breakthrough
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
